Page last updated: 2024-10-24

chloroquine and Liver Diseases

chloroquine has been researched along with Liver Diseases in 41 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Liver Diseases: Pathological processes of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Cadmium (Cd) is a type of high-risk heavy metal that can damage organs such as the liver, but its mechanism is not yet clear."5.72Cadmium induces liver dysfunction and ferroptosis through the endoplasmic stress-ferritinophagy axis. ( Fan, G; Feng, L; Fu, Y; Hao, H; He, Y; He, Z; Hu, X; Liu, Z; Shen, P; Wang, Y; Wu, J; Zhang, N; Zhu, K, 2022)
"Chloroquine has also been used as anti-inflammatory drugs to treat inflammatory diseases."5.39Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. ( Dahmen, U; Dirsch, O; Fang, H; Liu, A, 2013)
"Seventy-three patients with porphyria cutanea tarda (PCT) were treated with chloroquine phosphate, which was administered in doses of 250 mg twice a week for more than 1 year on average."3.67[Therapeutic and pathogenetic aspects of porphyria cutanea tarda]. ( Kemmer, C; Köstler, E; Riedel, H; Seebacher, C, 1986)
"Cadmium (Cd) is a type of high-risk heavy metal that can damage organs such as the liver, but its mechanism is not yet clear."1.72Cadmium induces liver dysfunction and ferroptosis through the endoplasmic stress-ferritinophagy axis. ( Fan, G; Feng, L; Fu, Y; Hao, H; He, Y; He, Z; Hu, X; Liu, Z; Shen, P; Wang, Y; Wu, J; Zhang, N; Zhu, K, 2022)
"Chloroquine has also been used as anti-inflammatory drugs to treat inflammatory diseases."1.39Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. ( Dahmen, U; Dirsch, O; Fang, H; Liu, A, 2013)
"Tetrahydrocurcumin (THC) is an antioxidative substance, which is derived from curcumin, the component of turmeric."1.33Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. ( Amali, DR; Pari, L, 2005)
"The porphyrias are caused by hereditary defects in the synthesis of heme."1.27The porphyrias. ( Rosen, T; Sekula, SA; Tschen, JA, 1986)

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-199033 (80.49)18.7374
1990's1 (2.44)18.2507
2000's1 (2.44)29.6817
2010's4 (9.76)24.3611
2020's2 (4.88)2.80

Authors

AuthorsStudies
He, Z2
Shen, P1
Feng, L1
Hao, H1
He, Y2
Fan, G1
Liu, Z3
Zhu, K1
Wang, Y3
Zhang, N1
Hu, X2
Fu, Y2
Wu, J2
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H4
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, Y3
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Wang, J4
Zhang, E1
Zhang, J3
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J7
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L2
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X5
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y4
Wu, X1
Lu, J2
Li, M1
Li, W2
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y4
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X4
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
Chen, B1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Fang, H1
Liu, A1
Dahmen, U1
Dirsch, O1
Lin, CW1
Chen, YS1
Lin, CC1
Chen, YJ1
Lo, GH1
Lee, PH1
Kuo, PL1
Dai, CY1
Huang, JF1
Chung, WL1
Yu, ML1
Cho, HI1
Kim, SJ1
Choi, JW1
Lee, SM2
Shin, JK1
Kang, JW1
SUBRAMANIAM, R1
GAMBARDELLA, A1
PATEL, JC1
GUNTHER, CE1
QUEEN, HO1
KERBEL, GA1
LANE, R1
THOMPSON, PE1
REINERTSON, JW1
HARRIS, JB1
WISE, RA1
ROOVERS, JJ1
VAN STEENIS, PB1
Pari, L1
Amali, DR1
Quattrocchi, G1
Armellini, C1
Riedel, H2
Justus, J1
Köstler, E2
Pätzold, K1
Kemmer, C2
Thomas, HC1
Bassendine, MF1
Campo, JM1
Milazzo, A1
Pascual, J1
Salcedo, J1
Labarga, P1
Yanguela, J1
Goerz, G1
Strohmeyer, G1
Martásek, P3
Jirsa, M3
Kordac, V5
Holvay, E1
Kaláb, M3
Semrádová, M1
Papezová, R1
Soldátová, H2
Vatti, R1
Sharma, OP1
Suzuki, S1
Chlumský, J1
Dobiás, J1
Chlumská, A1
Malina, L2
Haider, Z1
Rasul, A1
Ahmad, I1
Seebacher, C1
Doss, MO1
Enríquez de Salamanca, R1
Cervinka, J1
Kotal, P1
Marecek, Z1
Papezová, P1
Sekula, SA1
Tschen, JA1
Rosen, T1
Zoubek, V1
Braun, HJ1
Campbell, CH1
Holiday, J1
Biggs, JC1
Backhouse, TC1
Rousset, JJ1
Paraf, A1
Trad, J1
Benchetrit, J1
Klein, E1

Reviews

6 reviews available for chloroquine and Liver Diseases

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Immunological and anti-viral therapy of chronic hepatitis B virus infection.
    Clinics in gastroenterology, 1980, Volume: 9, Issue:1

    Topics: Adjuvants, Immunologic; Antibody Formation; Antiviral Agents; Carcinoma, Hepatocellular; Chloroquine

1980
[Fasciola hepatica. Review and current status of the disease].
    Revista clinica espanola, 1984, May-31, Volume: 173, Issue:4

    Topics: Animals; Chloroquine; Cholestasis, Intrahepatic; Emetine; Fasciola hepatica; Fascioliasis; Humans; I

1984
[Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Zeitschrift fur Hautkrankheiten, 1988, Apr-15, Volume: 63, Issue:4

    Topics: Chloroquine; Humans; Liver Diseases; Porphyrias; Skin Diseases

1988
[Porphyria hepatocutaneous tarda. Etiopathogenesis and physiopathologic treatment].
    Anales de la Real Academia Nacional de Medicina, 1987, Volume: 104, Issue:4

    Topics: Chloroquine; Humans; Liver Diseases; Plasma Exchange; Porphyrias; Porphyrins; Skin Diseases

1987
[Clinical picture, diagnostics and therapy of amyloidoses].
    Medizinische Klinik, 1972, Oct-06, Volume: 67, Issue:40

    Topics: Adrenal Gland Diseases; Amyloidosis; Biopsy; Chloroquine; Chronic Disease; Gastrointestinal Diseases

1972

Trials

2 trials available for chloroquine and Liver Diseases

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 1997, Volume: 14, Issue:1

    Topics: Adult; Aged; Alkaline Phosphatase; Antirheumatic Agents; Chloroquine; Diagnosis, Differential; Disea

1997

Other Studies

34 other studies available for chloroquine and Liver Diseases

ArticleYear
Cadmium induces liver dysfunction and ferroptosis through the endoplasmic stress-ferritinophagy axis.
    Ecotoxicology and environmental safety, 2022, Oct-15, Volume: 245

    Topics: Autophagy; Cadmium; Chloroquine; Deferoxamine; Endoplasmic Reticulum Stress; Ferritins; Ferroptosis;

2022
Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase.
    Cell death & disease, 2013, Jun-27, Volume: 4

    Topics: Animals; Anti-Inflammatory Agents; Antimalarials; Apoptosis; Autophagy; Chloroquine; Cytokines; Gene

2013
Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy.
    Scientific reports, 2015, Oct-30, Volume: 5

    Topics: Amiodarone; Animals; Autophagy; Autophagy-Related Protein 7; Chloroquine; Disease Models, Animal; He

2015
Genipin alleviates sepsis-induced liver injury by restoring autophagy.
    British journal of pharmacology, 2016, Volume: 173, Issue:6

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Autophagy; Autophagy-Related Proteins; C

2016
Enhanced nitric oxide-mediated autophagy contributes to the hepatoprotective effects of ischemic preconditioning during ischemia and reperfusion.
    Nitric oxide : biology and chemistry, 2016, 08-31, Volume: 58

    Topics: Animals; Autophagy; Chloroquine; Guanidines; Imidazoles; Ischemia; Ischemic Preconditioning; Liver;

2016
Resochin in the treatment of amoebiasis of the liver.
    The Indian medical gazette, 1952, Volume: 87, Issue:7

    Topics: Amebiasis; Chloroquine; Dysentery, Amebic; Liver Diseases

1952
[Further contribution on chloroquin (Resochin Bayer) therapy in emetine-resistant amebic hepatitis].
    Acta medica Italica di malattie infettive e parassitarie, 1952, Volume: 7, Issue:10

    Topics: Amebiasis; Chloroquine; Dysentery, Amebic; Emetine; Hepatitis; Humans; Liver Diseases

1952
Chloroquine in the treatment of amoebic liver abscess.
    British medical journal, 1953, Apr-11, Volume: 1, Issue:4814

    Topics: Amebiasis; Chloroquine; Dysentery, Amebic; Liver Abscess, Amebic; Liver Diseases

1953
Sidelights on chloroquine: two cases of interest.
    The Medical journal of Australia, 1953, Apr-25, Volume: 1, Issue:17

    Topics: Amebiasis; Chloroquine; Liver Diseases; Malaria

1953
Hepatic amebiasis treated with plaquenil: case report.
    North Carolina medical journal, 1960, Volume: 21

    Topics: Amebiasis; Chloroquine; Hydroxychloroquine; Liver Abscess, Amebic; Liver Diseases; North Carolina

1960
CRYOGLOBULINEMIA BASED ON INTERACTION BETWEEN A 19S AND A 7S GAMMA GLOBULIN.
    Archives of dermatology, 1964, Volume: 89

    Topics: Bence Jones Protein; Blood Chemical Analysis; Chloroquine; Cryoglobulinemia; Cryoglobulins; gamma-Gl

1964
The treatment of hepatic amoebiasis with chloroquine.
    The Journal of tropical medicine and hygiene, 1951, Volume: 54, Issue:10

    Topics: Amebiasis; Chloroquine; Dysentery, Amebic; Liver Abscess, Amebic; Liver Diseases

1951
Chemotherapy of amebic hepatitis in hamsters with emetine, chloroquine, amodiaquin (camoquin), quinacrine and other drugs.
    The American journal of tropical medicine and hygiene, 1951, Volume: 31, Issue:6

    Topics: Amebiasis; Amodiaquine; Chloroquine; Dysentery, Amebic; Emetine; Hepatitis; Liver Diseases; Quinacri

1951
Chloroquine treatment of amebic liver abscess.
    American practitioner and digest of treatment, 1952, Volume: 3, Issue:2

    Topics: Chloroquine; Liver Abscess, Amebic; Liver Diseases

1952
[Chloroquine therapy of liver abscess].
    Nederlands tijdschrift voor geneeskunde, 1951, Nov-10, Volume: 95, Issue:45

    Topics: Amebiasis; Chloroquine; Emetine; Liver Abscess; Liver Diseases

1951
Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2005, Apr-30, Volume: 8, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Chloroquine; Curcuma; Curcumin; Female; Liver Disea

2005
[Anatomo-functional research on the action of chloroquine at the hepatic level].
    Bollettino della Societa italiana di biologia sperimentale, 1967, Jun-15, Volume: 43, Issue:11

    Topics: Animals; Chloroquine; Female; Liver; Liver Diseases; Male; Necrosis; Rats

1967
[Morphology of liver damage in chronic hepatic porphyria with special reference to the effect of therapy].
    Der Pathologe, 1984, Volume: 5, Issue:4

    Topics: Adult; Aged; Biopsy; Bloodletting; Chloroquine; Female; Humans; Inclusion Bodies; Liver; Liver Disea

1984
[Porphyria cutanea tarda (PCT)].
    Der Internist, 1983, Volume: 24, Issue:10

    Topics: Bloodletting; Chloroquine; Diagnosis, Differential; Female; Humans; Liver Diseases; Male; Porphyrias

1983
[The effect of chloroquine therapy on the level of porphyrins in the liver in symptomatic hepatic porphyria].
    Ceskoslovenska gastroenterologie a vyziva, 1982, Volume: 36, Issue:3-4

    Topics: Adult; Aged; Chloroquine; Humans; Liver; Liver Diseases; Middle Aged; Porphyrias

1982
Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Therapia Hungarica (English edition), 1981, Volume: 29, Issue:1

    Topics: Adult; Chloroquine; Dose-Response Relationship, Drug; Humans; Liver Diseases; Male; Middle Aged; Por

1981
[Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Casopis lekaru ceskych, 1981, Oct-08, Volume: 120, Issue:40

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chloroquine; Female; Humans; Infant; Liver Disease

1981
[Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
    Casopis lekaru ceskych, 1981, Oct-15, Volume: 120, Issue:41

    Topics: Adult; Aged; Animals; Chloroquine; Female; Humans; Liver Diseases; Male; Middle Aged; Porphyrias; Po

1981
[Studies on lysosomes in hepatic disorders (author's transl)].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1979, Volume: 54, Issue:2

    Topics: Acid Phosphatase; Animals; Chemical and Drug Induced Liver Injury; Chloroquine; Glucuronidase; Hexos

1979
[Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
    Casopis lekaru ceskych, 1977, Nov-11, Volume: 116, Issue:45

    Topics: Adult; Aged; Chloroquine; Drug Tolerance; Female; Humans; Liver; Liver Diseases; Male; Middle Aged;

1977
Amoebic liver abscees presenting as obstructive jaundice: a case report.
    The Journal of tropical medicine and hygiene, 1975, Volume: 78, Issue:6

    Topics: Amoeba; Biopsy, Needle; Chloroquine; Cholestasis; Diagnosis, Differential; Emetine; Humans; Liver Ab

1975
[Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1986, Volume: 37, Issue:4

    Topics: Alcoholism; Chloroquine; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Drug Admi

1986
[2 years' experience with combined therapy of symptomatic liver porphyria using pyrimethamine and chloroquine].
    Casopis lekaru ceskych, 1988, Mar-04, Volume: 127, Issue:10

    Topics: Adult; Chloroquine; Drug Therapy, Combination; Female; Humans; Liver Diseases; Male; Middle Aged; Po

1988
The porphyrias.
    American family physician, 1986, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Aminolevulinic Acid; beta Carotene; Bloodletting; Carotenoids; Child; Child, Pres

1986
Treatment of chronic hepatic porphyria (PCT).
    Photo-dermatology, 1986, Volume: 3, Issue:2

    Topics: Bloodletting; Chloroquine; Humans; Hydroxychloroquine; Liver Diseases; Porphyrias

1986
[Experience with the therapy of symptomatic liver porphyria using a combination of antimalarial agents--chloroquine with pyrimethamine].
    Casopis lekaru ceskych, 1987, Feb-06, Volume: 126, Issue:6

    Topics: Adult; Aged; Chloroquine; Drug Therapy, Combination; Humans; Liver Diseases; Male; Middle Aged; Porp

1987
Chloroquine-resistant Falciparum malaria acquired in Vietnam.
    The Medical journal of Australia, 1973, Oct-13, Volume: 2, Issue:15

    Topics: Acute Kidney Injury; Adolescent; Adult; Blood Cell Count; Chloroquine; Dapsone; Drug Resistance, Mic

1973
[Apropos of a case of hepatic distomatosis due to Fasciola gigantica contracted in Cameroon].
    Bulletin de la Societe de pathologie exotique et de ses filiales, 1968, Volume: 61, Issue:2

    Topics: Abscess; Adult; Anxiety; Buttocks; Cameroon; Chloroquine; Delirium; Emetine; Eosinophilia; Fasciola;

1968
[Clinical observations in patients with acute amebic dysentery].
    Medizinische Klinik, 1968, Jul-05, Volume: 63, Issue:27

    Topics: Acute Disease; Chloroquine; Colitis, Ulcerative; Diagnosis, Differential; Dysentery, Amebic; Emetine

1968